Inhalation Sciences Sweden AB (publ)
Research Inhalation Sciences Sweden AB (publ) (ISAB.ST) on Bullrun: market cap SEK 3.12M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerISAB.ST
- ExchangeXSAT
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Market capSEK 3.12M
- Financial periodQ2 2026
- RevenueSEK 2.70M
- Net income-SEK 1.75M
- Free cash flow-SEK 1.59M
- Gross margin68.1%
Valuation Snapshot
latest market cap is SEK 3.12M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | SEK 3.12M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Inhalation Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research in Sweden. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Inhalation Sciences Sweden AB (publ)'s market cap?
Inhalation Sciences Sweden AB (publ)'s market capitalization is SEK 3.12M.
What does Inhalation Sciences Sweden AB (publ) do?
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research in Sweden. The company offers PreciseInhale, a laboratory system that allows scientists to measure how inhaled particles act in lungs and affect the health; DissolvIt, which enables in vitro simulation of dissolution and absorption of respirable particles in the lung epithelium; XposeALI, a 3D cell exposure module that combines aerosol capability with 3D cell models cultured at an air liquid interface; Nose-only inhalation, a standard method of exposure used in preclinical testing of inhalation.